To ascertain whether the PTT-mediated tumor irradiation at the primary site may amplify systemic immune responses that would affect abscopal tumors, we determined Her2 (p66; TYVPANASL) peptide-specific IFN-γ producing cells in the tdLNs of abscopal tumors. This evidence concerns the gene ERBB2 and neoplasm.